Cargando…

A risk measurement tool for targeted HIV prevention measures amongst young pregnant and lactating women in South Africa

BACKGROUND: We aimed to develop and validate a tool to identify which pregnant/lactating young South African women (≤ 24 years) are at risk of HIV infection. METHODS: Data from three national South African Prevention of Mother-to-Child Transmission (PMTCT) evaluations were used to internally validat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramraj, Trisha, Abdelatif, Nada, Chirinda, Witness, Abdullah, Fareed, Kindra, Gurpreet, Goga, Ameena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248185/
https://www.ncbi.nlm.nih.gov/pubmed/35773638
http://dx.doi.org/10.1186/s12889-022-13625-8
_version_ 1784739317428518912
author Ramraj, Trisha
Abdelatif, Nada
Chirinda, Witness
Abdullah, Fareed
Kindra, Gurpreet
Goga, Ameena
author_facet Ramraj, Trisha
Abdelatif, Nada
Chirinda, Witness
Abdullah, Fareed
Kindra, Gurpreet
Goga, Ameena
author_sort Ramraj, Trisha
collection PubMed
description BACKGROUND: We aimed to develop and validate a tool to identify which pregnant/lactating young South African women (≤ 24 years) are at risk of HIV infection. METHODS: Data from three national South African Prevention of Mother-to-Child Transmission (PMTCT) evaluations were used to internally validate three HIV acquisition risk models for young postpartum women. We used univariate and multivariable logistic regression analysis to determine which risk factors were significant. Model coefficients were rounded and stratified into risk groups and the area under the receiver operating curve (AUROC) was computed. Models were developed to determine which risk factors provided the most predictive accuracy whilst remining clinically meaningful. RESULTS: Data from 9 456 adult and 4 658 young pregnant and lactating women were included in the development and validation data sets, respectively. The optimal model included the following risk factors: age (20–24 years old), informal house structure, two or more pregnancies, mothers who had knowledge of when they received their last HIV test result, no knowledge of the infant’s father’s HIV status, no knowledge of breastfeeding as a mode of MTCT and knowledge of PMTCT programme. The mean AUROC was 0.71 and 0.72 in the development and validation datasets respectively. The optimum cut off score was ≥ 27, having 84% sensitivity, 44% specificity, and identifying 44% of high-risk women eligible for PrEP. CONCLUSION: The optimal model to be used as a possible risk scoring tool to allow for early identification of those pregnant/lactating women most at-risk of HIV acquisition included both statistically as well as clinically meaningful risk factors. A field-based study is needed to test and validate the effectiveness of this targeted approach.
format Online
Article
Text
id pubmed-9248185
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92481852022-07-02 A risk measurement tool for targeted HIV prevention measures amongst young pregnant and lactating women in South Africa Ramraj, Trisha Abdelatif, Nada Chirinda, Witness Abdullah, Fareed Kindra, Gurpreet Goga, Ameena BMC Public Health Research BACKGROUND: We aimed to develop and validate a tool to identify which pregnant/lactating young South African women (≤ 24 years) are at risk of HIV infection. METHODS: Data from three national South African Prevention of Mother-to-Child Transmission (PMTCT) evaluations were used to internally validate three HIV acquisition risk models for young postpartum women. We used univariate and multivariable logistic regression analysis to determine which risk factors were significant. Model coefficients were rounded and stratified into risk groups and the area under the receiver operating curve (AUROC) was computed. Models were developed to determine which risk factors provided the most predictive accuracy whilst remining clinically meaningful. RESULTS: Data from 9 456 adult and 4 658 young pregnant and lactating women were included in the development and validation data sets, respectively. The optimal model included the following risk factors: age (20–24 years old), informal house structure, two or more pregnancies, mothers who had knowledge of when they received their last HIV test result, no knowledge of the infant’s father’s HIV status, no knowledge of breastfeeding as a mode of MTCT and knowledge of PMTCT programme. The mean AUROC was 0.71 and 0.72 in the development and validation datasets respectively. The optimum cut off score was ≥ 27, having 84% sensitivity, 44% specificity, and identifying 44% of high-risk women eligible for PrEP. CONCLUSION: The optimal model to be used as a possible risk scoring tool to allow for early identification of those pregnant/lactating women most at-risk of HIV acquisition included both statistically as well as clinically meaningful risk factors. A field-based study is needed to test and validate the effectiveness of this targeted approach. BioMed Central 2022-06-30 /pmc/articles/PMC9248185/ /pubmed/35773638 http://dx.doi.org/10.1186/s12889-022-13625-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ramraj, Trisha
Abdelatif, Nada
Chirinda, Witness
Abdullah, Fareed
Kindra, Gurpreet
Goga, Ameena
A risk measurement tool for targeted HIV prevention measures amongst young pregnant and lactating women in South Africa
title A risk measurement tool for targeted HIV prevention measures amongst young pregnant and lactating women in South Africa
title_full A risk measurement tool for targeted HIV prevention measures amongst young pregnant and lactating women in South Africa
title_fullStr A risk measurement tool for targeted HIV prevention measures amongst young pregnant and lactating women in South Africa
title_full_unstemmed A risk measurement tool for targeted HIV prevention measures amongst young pregnant and lactating women in South Africa
title_short A risk measurement tool for targeted HIV prevention measures amongst young pregnant and lactating women in South Africa
title_sort risk measurement tool for targeted hiv prevention measures amongst young pregnant and lactating women in south africa
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248185/
https://www.ncbi.nlm.nih.gov/pubmed/35773638
http://dx.doi.org/10.1186/s12889-022-13625-8
work_keys_str_mv AT ramrajtrisha ariskmeasurementtoolfortargetedhivpreventionmeasuresamongstyoungpregnantandlactatingwomeninsouthafrica
AT abdelatifnada ariskmeasurementtoolfortargetedhivpreventionmeasuresamongstyoungpregnantandlactatingwomeninsouthafrica
AT chirindawitness ariskmeasurementtoolfortargetedhivpreventionmeasuresamongstyoungpregnantandlactatingwomeninsouthafrica
AT abdullahfareed ariskmeasurementtoolfortargetedhivpreventionmeasuresamongstyoungpregnantandlactatingwomeninsouthafrica
AT kindragurpreet ariskmeasurementtoolfortargetedhivpreventionmeasuresamongstyoungpregnantandlactatingwomeninsouthafrica
AT gogaameena ariskmeasurementtoolfortargetedhivpreventionmeasuresamongstyoungpregnantandlactatingwomeninsouthafrica
AT ramrajtrisha riskmeasurementtoolfortargetedhivpreventionmeasuresamongstyoungpregnantandlactatingwomeninsouthafrica
AT abdelatifnada riskmeasurementtoolfortargetedhivpreventionmeasuresamongstyoungpregnantandlactatingwomeninsouthafrica
AT chirindawitness riskmeasurementtoolfortargetedhivpreventionmeasuresamongstyoungpregnantandlactatingwomeninsouthafrica
AT abdullahfareed riskmeasurementtoolfortargetedhivpreventionmeasuresamongstyoungpregnantandlactatingwomeninsouthafrica
AT kindragurpreet riskmeasurementtoolfortargetedhivpreventionmeasuresamongstyoungpregnantandlactatingwomeninsouthafrica
AT gogaameena riskmeasurementtoolfortargetedhivpreventionmeasuresamongstyoungpregnantandlactatingwomeninsouthafrica